Penn Pharma provides a selection of Contract Development and Manufacturing Organisation services.

Investment type
  • Secondary buyout
Deal value


Exit type
  • Trade sale
Exit date

August 2014

Exit value


The Team
LDC Team
Quote mark

LDC’s support and strategic input to our business has been invaluable, and ensures that we are now well placed to embark upon the next stage of our growth plans.”

Dr Richard Yarwood, Former Chief Executive
Penn Pharmaceuticals

Patient capital

During the seven years that LDC backed the business, Penn saw annual turnover rise from £17m in 2007 to over £30m in 2014, and the workforce grew to 300-strong, a 47 per cent increase since our original investment.

We completed a trade sale in 2014 to Packaging Co-ordinators Inc, a USA-headquartered global packaging services provider in a £127m deal, delivering a 2.9x return.


Exit Management Team of the Year

Penn Pharma – Wales BVCA Management Team Awards

Venture Capital Deal of the Year

Penn Pharma – Insider Wales Dealmaker Awards